Yayın:
Antihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBarbaros, Mustafa Burak
dc.contributor.authorTURAN YÜCEL, NAZLI
dc.contributor.authorCAN, ÖZGÜR DEVRİM
dc.contributor.authorÜçel, Umut İrfan
dc.contributor.authorDEMİR ÖZKAY, ÜMİDE
dc.contributor.orcid0000-0002-2260-3174
dc.contributor.orcid0000-0002-5470-0139
dc.contributor.orcid0000-0002-0371-2703
dc.contributor.orcid0000-0002-6773-4266
dc.date.accessioned2025-11-13T11:22:31Z
dc.date.issued2018-08-19
dc.identifier.doihttps://doi.org/10.3390/molecules23082072
dc.identifier.endpage2072
dc.identifier.issn1420-3049
dc.identifier.issue8
dc.identifier.openalexW2886356516
dc.identifier.startpage2072
dc.identifier.urihttps://hdl.handle.net/11421/6590
dc.identifier.urihttps://doi.org/10.3390/molecules23082072
dc.identifier.volume23
dc.language.isoen
dc.relation.ispartofMolecules
dc.rightsopenAccess
dc.subjectAtomoxetine
dc.subjectNeuropathic pain
dc.subjectDopaminergic
dc.subjectPharmacology
dc.subjectPhentolamine
dc.subjectMedicine
dc.subjectDiabetes mellitus
dc.subjectSulpiride
dc.subjectHyperalgesia
dc.subjectYohimbine
dc.subjectAnesthesia
dc.subjectNociception
dc.subjectDopamine
dc.subjectInternal medicine
dc.subjectEndocrinology
dc.subjectPropranolol
dc.subjectReceptor
dc.subjectMethylphenidate
dc.subjectPsychiatry
dc.subjectAntagonist
dc.subject.sdg3
dc.titleAntihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5067862683
local.authorid.openalexA5018664863
local.authorid.openalexA5020313406
local.authorid.openalexA5063203563
local.authorid.openalexA5017325490

Dosyalar

Koleksiyonlar

Publications